Tobacco control and household tobacco consumption: A tale of two educational groups.


Journal

Health economics
ISSN: 1099-1050
Titre abrégé: Health Econ
Pays: England
ID NLM: 9306780

Informations de publication

Date de publication:
10 2020
Historique:
received: 31 05 2019
revised: 13 03 2020
accepted: 04 06 2020
pubmed: 23 6 2020
medline: 28 7 2021
entrez: 23 6 2020
Statut: ppublish

Résumé

Since the ratification of the World Health Organization Framework Convention on Tobacco Control in 2004, Pakistan has made modest but continued progress in implementing various tobacco control measures. By 2014, substantial progress was achieved in areas of monitoring, mass media antitobacco campaigns, and advertising bans. However, the findings from the 2014 Global Adult Tobacco Survey of Pakistan show significant differences in antitobacco campaign exposure among individuals of different educational attainment. Given this large variation in noticing antitobacco information, this paper analyzes how heterogeneity in treatment exposure may differentially impact tobacco-use prevalence across household groups. Household-level tobacco-use prevalence in 2014 was, respectively, 56% and 48% for the low- and high-education households. The gap in tobacco-use prevalence between the two educational groups further widens post 2014. We find that, on average, individuals with higher than primary education are 14 percentage points and 6 percentage points more likely to notice anticigarette and antismokeless tobacco information in 2014, respectively. Subsequently, in 2016, high-education households experienced a 3.6 percentage point higher reduction in tobacco-use prevalence compared to the low-education households. These findings motivate policies to enhance the outreach of tobacco control measures across different educational groups.

Identifiants

pubmed: 32567200
doi: 10.1002/hec.4122
pmc: PMC7540029
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1117-1131

Informations de copyright

© 2020 The Authors. Health Economics published by John Wiley & Sons Ltd.

Références

Tob Control. 2012 May;21(3):341-6
pubmed: 21828230
Tob Control. 2018 Jan;27(1):50-57
pubmed: 27956650
Health Econ. 2020 Oct;29(10):1117-1131
pubmed: 32567200
Addiction. 2013 Aug;108(8):1476-84
pubmed: 23451932
Nicotine Tob Res. 2019 Jun 21;21(7):887-895
pubmed: 30452728
Tob Control. 2006 Jun;15 Suppl 3:iii19-25
pubmed: 16754942
Salud Publica Mex. 2010;52 Suppl 2:S206-15
pubmed: 21243191
Tob Control. 2012 Jan;21(1):12-7
pubmed: 21508418
Tob Control. 2015 Nov;24(6):540-2
pubmed: 25492934
Am J Public Health. 2008 Aug;98(8):1443-50
pubmed: 18556601
Tob Control. 2009 Oct;18(5):358-64
pubmed: 19561362
Tob Control. 2016 May;25(3):341-54
pubmed: 25948713
Prev Med. 2017 Dec;105S:S10-S14
pubmed: 28502576
Soc Sci Med. 2006 Mar;62(6):1414-26
pubmed: 16137812
Tob Control. 2014 Nov;23(e2):e89-97
pubmed: 24046211
Popul Health Metr. 2013 Sep 03;11(1):16
pubmed: 24004968
Tob Control. 2012 Mar;21(2):127-38
pubmed: 22345235
Int J Public Health. 2011 Jun;56(3):253-62
pubmed: 21181228
Lancet Public Health. 2017 Apr;2(4):e166-e174
pubmed: 29253448
Nicotine Tob Res. 2013 Aug;15(8):1339-47
pubmed: 23291637
Tob Control. 2011 Sep;20(5):327-37
pubmed: 21606180
Tob Control. 2015 Mar;24(e1):e72-80
pubmed: 25701880
Tob Control. 2018 Jan;27(1):26-34
pubmed: 27885168
Int J Equity Health. 2014 Feb 06;13:14
pubmed: 24502335
Nicotine Tob Res. 2013 Apr;15(4):817-31
pubmed: 23042986
PLoS One. 2012;7(3):e33466
pubmed: 22438937
J Health Econ. 2008 Jul;27(4):930-942
pubmed: 18440661
J Health Econ. 2019 Sep;67:102215
pubmed: 31319336
Tob Control. 2015 Jul;24 Suppl 3:iii71-iii75
pubmed: 25701857
Soc Sci Med. 2008 Nov;67(9):1343-55
pubmed: 18691793

Auteurs

Biplab Kumar Datta (BK)

Global Noncommunicable Diseases Branch, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Muhammad Jami Husain (MJ)

Global Noncommunicable Diseases Branch, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Ishtiaque Fazlul (I)

Department of Economics, Georgia State University, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH